Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ZNTL
#3159
Zentalis Pharmaceuticals, Inc. Common Stock
5.3
6
USD
+3.28%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+3.28%
Monthly Change
+98.52%
6 month change
+248.05%
Year Change
+335.77%
Previous Close
5.1
9
Open
5.3
6
Bid
Ask
Low
5.3
6
High
5.3
6
Volume
63
Markets
US Stock Market
Healthcare
ZNTL
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Market Capitalization
380.19 M
Employee
106
Founded
2014
CEO
N/A
Website
www.zentalis.com
Headquarter
California, United States
FIGI
BBG00R2K8TF5
Industry
Biotechnology
News
What's Behind The Surge In Zentalis Stock? - Zentalis Pharmaceuticals (NASDAQ:ZNTL)
Wells Fargo assumes coverage on Zentalis stock with $5 target
Zentalis Pharma CEO Eastland sells $21k in shares
Zentalis Pharma CMO Bruns sells $7998 in stock
Zentalis Pharmaceuticals: Late Stage, Lots Of Cash, Crushed By The Market
Zentalis Pharmaceuticals: Hanging On For One Last Shot At PROC Approval (ZNTL)
Zentalis Pharmaceuticals stock price target lowered to $2 at Leerink Partners
Zentalis to present azenosertib data at cancer therapeutics conference
Zentalis Pharmaceuticals shareholders elect three directors at annual meeting
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
H.C. Wainwright maintains buy rating on Zentalis stock after ASCO update
Zentalis Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Progress